Effect of sphingomyelinase treatment on ligand binding activity of human serotonin1A receptors

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 10, 2008, Pages 2022-2025

  Jafurulla, Md ^a   Pucadyil, Thomas J ^a   Chattopadhyay, Amitabha ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Fluorescence anisotropy; Ligand binding activity; Serotonin1A receptor; Sphingomyelin; Sphingomyelinase

Indexed keywords

1 PHENYL 6 [4 (TRIMETHYLAMMONIO)PHENYL] 1,3,5 HEXATRIENE; CERAMIDE; NEUROTRANSMITTER RECEPTOR; PHOSPHORYLCHOLINE; SEROTONIN 1A RECEPTOR; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TRIMETHYLAMMONIUM SALT DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANISOTROPY; ARTICLE; BEHAVIOR; BINDING ASSAY; CHO CELL; COGNITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MECHANISM; FLUORESCENCE; LIGAND BINDING; MEMBRANE BINDING; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; RECEPTOR AFFINITY; RECEPTOR BINDING; REGULATORY MECHANISM;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; LIGANDS; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS;

EID: 52049084115     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.07.007     Document Type: Article

References (32)

1. Holthuis J.C., Pomorski T., Raggers R.J., Sprong H., and van Meer G. The organizing potential of sphingolipids in intracellular membrane transport. Physiol. Rev. 81 (2001) 1689-1723
2. Brown R.E. Sphingolipid organization in biomembranes: what physical studies of model membranes reveal. J. Cell Sci. 111 (1998) 1-9
3. Ramstedt B., and Slotte J.P. Sphingolipids and the formation of sterol-enriched ordered membrane domains. Biochim. Biophys. Acta 1758 (2006) 1945-1956
4. Peroutka S.J., and Howell T.A. The molecular evolution of G-protein coupled receptors: focus on 5-hydroxytryptamine receptors. Neuropharmacology 33 (1994) 319-324
5. Schöneberg T., Hofreiter M., Schulz A., and Römpler H. Learning from the past: evolution of GPCR functions. Trends Pharmacol. Sci. 28 (2007) 117-121
6. 1A receptor: a representative member of the serotonin receptor family. Cell. Mol. Neurobiol. 25 (2005) 553-580
7. 1A-receptors. Prog. Neurobiol. 81 (2007) 133-178
8. Blier P., and de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15 (1994) 220-226
9. 1A receptor blockers as potential drug candidates for the treatment of anxiety disorders. Drug News Perspect. 12 (1999) 484-490
10. Gingrich J.A., and Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology 155 (2001) 1-10
11. 1A receptor knockout mouse as a genetic model of anxiety. Eur. J. Pharmacol. 463 (2003) 177-184
12. Pucadyil T.J., and Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog. Lipid Res. 45 (2006) 295-333
13. 1A receptor. Cell. Mol. Neurobiol. 27 (2007) 1097-1116
14. van Echten-Deckert G., and Herget T. Sphingolipid metabolism in neural cells. Biochim. Biophys. Acta 1758 (2006) 1978-1994
15. Posse de Chaves E.I. Sphingolipids in apoptosis, survival and regeneration in the nervous system. Biochim. Biophys. Acta 1758 (2006) 1995-2015
16. 1A receptor heterologously expressed in CHO cells. Biosci. Rep. 24 (2004) 101-115
17. 7(a) receptors in HeLa cells. Acta Physiol. 190 (2007) 47-53
18. Chatterjee S. Neutral sphingomyelinase: past, present and future. Chem. Phys. Lipids 102 (1999) 79-96
19. Goñi F.M., and Alonso A. Sphingomyelinases: enzymology and membrane activity. FEBS Lett. 531 (2002) 38-46
20. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
21. van Echten-Deckert G. Sphingolipid extraction and analysis by thin-layer chromatography. Methods Enzymol. 312 (2000) 64-79
22. McClare C.W.F. An accurate and convenient organic phosphorus assay. Anal. Biochem. 39 (1971) 527-530
23. Jayadev S., Liu B., Bielawska A.E., Lee J.Y., Nazaire F., Pushkareva M.Y., Obeid L.M., and Hannun Y.A. Role of ceramide in cell cycle arrest. J. Biol. Chem. 270 (1995) 2047-2052
24. Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D., Grant S., Birrer M.J., Szabo E., Zon L.I., Kyriakis J.M., Haimovitz-Friedman A., Fuks Z., and Kolesnick R.N. Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature 380 (1996) 75-79
25. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 (1985) 76-85
26. Prendergast F.G., Haugland R.P., and Callahan P.J. 1-[4-(Trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene: synthesis, fluorescence properties, and use as a fluorescence probe of lipid bilayers. Biochemistry 20 (1981) 7333-7338
27. Kuhry J.-G., Fonteneau P., Duportail G., Maechling C., and Laustriat G. TMA-DPH: a suitable fluorescence polarization probe for specific plasma membrane fluidity studies in intact living cells. Cell. Biophys. 5 (1983) 129-140
28. Kuhry J.-G., Duportail G., Bronner C., and Laustriat G. Plasma membrane fluidity measurements on whole living cells by fluorescence anisotropy of trimethylammoniumdiphenylhexatriene. Biochim. Biophys. Acta 845 (1985) 60-67
29. Lakowicz J.R. Principles of Fluorescence Spectroscopy. 3rd Ed. (2006), Springer, New York
30. 1A receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome. Biochim. Biophys. Acta 1778 (2008) 1508-1516
31. 1A receptor in the plasma membrane of living cells. Biochim. Biophys. Acta 1768 (2007) 655-668
32. 1A receptor monitored by detergent insolubility using GFP fluorescence. Mol. Membr. Biol. 22 (2005) 539-547